SARS-CoV-2 infection and Guillain-Barré syndrome

2Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Severe acute respiratory syndrome coronavirus strain 2 (SARS-CoV-2) is a beta-coronavirus that emerged as a global threat and caused a pandemic following its first outbreak in Wuhan, China, in late 2019. SARS-CoV-2 causes COVID-19, a disease ranging from relatively mild to severe illness. Older people and those with many serious underlying medical conditions such as diabetes, heart or lung conditions are at higher risk for developing severe complications from COVID-19 illness. SARS-CoV-2 infections of adults can lead to neurological complications ranging from headaches, loss of taste and smell, to Guillain–Barré syndrome, an autoimmune disease characterized by neurological deficits. Herein we attempt to describe the neurological manifestations of SARS-CoV2 infection with a special focus on Guillain-Barré syndrome.

Cite

CITATION STYLE

APA

Makhluf, H., & Madany, H. (2021, August 1). SARS-CoV-2 infection and Guillain-Barré syndrome. Pathogens. MDPI AG. https://doi.org/10.3390/pathogens10080936

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free